{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:17:23Z","timestamp":1767845843501,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.eururo.2014.11.054","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:01:14Z","timestamp":1418666474000},"page":"506-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies"],"prefix":"10.1016","volume":"68","author":[{"given":"Nils","family":"Kroeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan J.","family":"Pantuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Connor","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben","family":"Broom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg A.","family":"Bjarnason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoud","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Knox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezra","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Smoragiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian I.","family":"Rini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulka N.","family":"Vaishampayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Beuselinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frede","family":"Donskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Y.","family":"Heng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.11.054_bib0005","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/cncr.11422","article-title":"Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy","volume":"97","author":"Pantuck","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.11.054_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(05)66078-8","article-title":"Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma","volume":"166","author":"Vasselli","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0015","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1200\/JCO.2005.03.9594","article-title":"Impact of immune parameters on long-term survival in metastatic renal cell carcinoma","volume":"24","author":"Donskov","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0020","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.2005.05.179","article-title":"Validation and extension of the Memorial Sloan\u2013Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma","volume":"23","author":"Mekhail","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0025","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/annonc\/mdf257","article-title":"Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d\u2019Immunotherapie","volume":"13","author":"Negrier","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0035","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.eururo.2011.09.003","article-title":"Lymph node dissection in renal cell carcinoma","volume":"60","author":"Capitanio","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","article-title":"Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881","volume":"55","author":"Blom","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eururo.2008.09.056","article-title":"Lymphadenectomy combined with radical nephrectomy: to do or not to do?","volume":"55","author":"Studer","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.ju.0000129815.91927.85","article-title":"A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma","volume":"172","author":"Blute","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0055","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1097\/01.ju.0000066130.27119.1c","article-title":"Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection","volume":"169","author":"Pantuck","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0060","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.juro.2010.12.053","article-title":"Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases","volume":"185","author":"Whitson","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0065","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0070","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1002\/cncr.28151","article-title":"Metastatic non\u2013clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria","volume":"119","author":"Kroeger","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.11.054_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","article-title":"External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study","volume":"14","author":"Heng","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2013.08.012","article-title":"Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy","volume":"65","author":"McKay","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0085","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.juro.2014.02.480","article-title":"Lymphadenectomy at the time of surgery for high risk localized RCC: results from the ASSURE adjuvant trial (ECOG 2805)","volume":"191","author":"Uzzo","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1464-410X.2008.08014.x","article-title":"Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma","volume":"103","author":"Capitanio","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.11.054_bib0095","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.11.054_bib0100","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.eururo.2013.07.031","article-title":"Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy","volume":"65","author":"Kroeger","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.eururo.2012.01.012","article-title":"Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma","volume":"61","author":"Kroeger","year":"2012","journal-title":"Eur Urol"},{"issue":"Suppl 7","key":"10.1016\/j.eururo.2014.11.054_bib0110","article-title":"Anemia in cancer","volume":"21","author":"Dicato","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2014.11.054_bib0115","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2014.05.034","article-title":"Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium","volume":"66","author":"Heng","year":"2014","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814012494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814012494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:23:36Z","timestamp":1537993416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814012494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0302283814012494"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.11.054","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.11.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}